drugset / Trial / NCT03316859

Naloxegol and Opioid-induced Constipation

NCT03316859

Phase 2/3 Unknown 280 enrolled TriHealth Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a double-blind, randomized, placebo-controlled trial to examine the effectiveness of adding one 25mg dose of naloxegol to the cardiac surgery pre-operative regimen.

Timeline

Start
2017-11-06
Primary completion
2022-12-01
Completion
2022-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Naloxegol Small molecule 25 mg